Physician profile
Robert E Brookover
NPI 1376897629
$21,743.89
in general payments reported to CMS, 2019-2025
17 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,997 · 2020: $10K · 2021: $82.32 · 2022: $459 · 2023: $441 · 2024: $229 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,447.90 | 2019-2025 | Da Vinci Surgical System |
| Kerecis Limited | $266.14 | 2022 | |
| Medtronic, INC. | $226.90 | 2024-2025 | Signia, Sonicision, Maxtack |
| Conmed Corporation | $145.00 | 2023 | Airseal |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Activ Surgical, INC. | $121.58 | 2023 | Activsight |
| Prescient Surgical | $110.03 | 2019 | |
| Davol INC. | $83.38 | 2023-2024 | Phasix Mesh |
| Histosonics, INC. | $35.07 | 2024 | |
| Deciphera Pharmaceuticals INC. | $28.74 | 2024 | Qinlock |
| Tela Bio, INC. | $27.31 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Daiichi Sankyo INC. | $25.41 | 2024 | Injectafer |
| Taiho Oncology, INC. | $22.82 | 2023 | |
| Accord Healthcare, INC. | $22.60 | 2023 | |
| Amag Pharmaceuticals, INC. | $21.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.07 | 2022 | |
| Merck Sharp & Dohme LLC | $16.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brookover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.